Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria

This publication has 15 references indexed in Scilit:

• Pathophysiology of Progressive Nephropathies
  New England Journal of Medicine, 1998
• Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial
  The Lancet, 1998
• Understanding the nature of renal disease progression
  Kidney International, 1997
• Effect of the Angiotensin-Converting–Enzyme Inhibitor Benazepril on the Progression of Chronic Renal Insufficiency
  New England Journal of Medicine, 1996
• Blood Pressure Control, Proteinuria, and the Progression of Renal Disease
  Annals of Internal Medicine, 1995
• 56A Comparison of time-to-event and slope-based analyses in nephrology clinical trials
  Controlled Clinical Trials, 1995
• The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic Nephropathy
  New England Journal of Medicine, 1993
• Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat.
  Journal of Clinical Investigation, 1990
• Effect of antihypertensive treatment on kidney function in diabetic nephropathy.
  BMJ, 1987
• Repeated assessment of results in clinical trials of cancer treatment
  The British Journal of Radiology, 1971